author-photo

Debanjana Chatterjee

Eisai

27

Papers

237

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Racial-Ethnic Differences in Health-Related Quality of Life among Adults and Children with Glomerular Disease

2021
Show All
- Source
- Cite
- Save
Citations (0)
Lenvatinib and Subsequent Therapy for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Real-World Study of Clinical Effectiveness in the United States.

2020 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (11)
Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United States

2019 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (6)
167PUtilization and outcomes of Eribulin Mesylate POst a cyclin-dependent kinase 4/6 inhibitor (CDK 4/6i): An observational real-World study in UnitEd States community oncology pRactices (EMPOWER)

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Observational study of clinical outcomes of eribulin mesylate in metastatic breast cancer after cyclin-dependent kinase 4/6 inhibitor therapy

2019 Future Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Impact of disease progression on patient reported outcomes, hospitalization, and death in patients with stage IV, renal cell carcinoma.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Emotional Health Among Youth Experiencing Family Homelessness

2018 Pediatrics
Show All
- Source
- Cite
- Save
Citations (16)
Abstract P456: Examining Framingham Coronary Heart Disease 10-year Risk Reduction in Individuals Treated With Lorcaserin, a Selective 5HT2C Receptor Agonist for Weight Management

2017 Hypertension
Show All
- Source
- Cite
- Save
Citations (0)
Second or none: Many patients treated for refractory differentiated thyroid cancer with small molecular kinase inhibitors do not receive a second line of therapy.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P458: Assessment of Cardiovascular Risk Reduction in Adults With Metabolic Syndrome or Type 2 Diabetes Treated With Lorcaserin: A Pooled Cohort Analysis

2017 Hypertension
Show All
- Source
- Cite
- Save
Citations (0)